DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Mayer IA, Abramson VG, Isakoff SJ et al.
Stand up to cancer phase Ib study of pan-phosphoinositide-3-kinase inhibitor buparlisib with letrozole in estrogen receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer.
J Clin Oncol 2014;
32: 1202-1209
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.